The binding of surface molecules involved in T cell activation, especially CD26 and CD147, to the SARS-CoV-2-S protein contribute to the lymphopenia reported in COVID-19-patients through activation-induced T cell death [37]. The gene discussed is BSG; the disease is lymphopenia.